An Open-Label, Randomised Study of Dihydroartemisinin-Piperaquine Versus Artesunate-Mefloquine for Falciparum Malaria in Asia

BACKGROUND: The artemisinin-based combination treatment (ACT) of dihydroartemisinin (DHA) and piperaquine (PQP) is a promising novel anti-malarial drug effective against multi-drug resistant falciparum malaria. The aim of this study was to show non-inferiority of DHA/PQP vs. artesunate-mefloquine (A...

Descripción completa

Detalles Bibliográficos
Autores principales: Valecha, Neena, Phyo, Aung Pyae, Mayxay, Mayfong, Newton, Paul N., Krudsood, Srivicha, Keomany, Sommay, Khanthavong, Maniphone, Pongvongsa, Tiengkham, Ruangveerayuth, Ronnatrai, Uthaisil, Chirapong, Ubben, David, Duparc, Stephan, Bacchieri, Antonella, Corsi, Marco, Rao, Bappanad H. K., Bhattacharya, Prabash C., Dubhashi, Nagesh, Ghosh, Susanta K., Dev, Vas, Kumar, Ashwani, Pukittayakamee, Sasithon
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2912766/
https://www.ncbi.nlm.nih.gov/pubmed/20689583
http://dx.doi.org/10.1371/journal.pone.0011880

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2912766/
https://www.ncbi.nlm.nih.gov/pubmed/20689583
http://dx.doi.org/10.1371/journal.pone.0011880

Ejemplares similares